Nemolizumab and Atopic Dermatitis: the Interaction Between Interleukin-31 and Interleukin-31 Receptor as a Potential Therapeutic Target for Pruritus in Patients With Atopic Dermatitis

Takeshi Nakahara, Masutaka Furue

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Nemolizumab and Atopic Dermatitis: the Interaction Between Interleukin-31 and Interleukin-31 Receptor as a Potential Therapeutic Target for Pruritus in Patients With Atopic Dermatitis'. Together they form a unique fingerprint.

Medicine & Life Sciences